To the best our knowledge, this is the first study on a Moroccan population, assessing the risk of GSTM1 and GSTT1 null genotype carriers in the development of CML. The gene discussed is GSTM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.